152 related articles for article (PubMed ID: 9135015)
1. Deregulated apoptosis is a hallmark of the Fanconi anemia syndrome.
Ridet A; Guillouf C; Duchaud E; Cundari E; Fiore M; Moustacchi E; Rosselli F
Cancer Res; 1997 May; 57(9):1722-30. PubMed ID: 9135015
[TBL] [Abstract][Full Text] [Related]
2. Fanconi anemia C protein acts at a switch between apoptosis and necrosis in mitomycin C-induced cell death.
Guillouf C; Wang TS; Liu J; Walsh CE; Poirier GG; Moustacchi E; Rosselli F
Exp Cell Res; 1999 Feb; 246(2):384-94. PubMed ID: 9925754
[TBL] [Abstract][Full Text] [Related]
3. Tumor necrosis factor-alpha and CD95 ligation suppress erythropoiesis in Fanconi anemia C gene knockout mice.
Otsuki T; Nagakura S; Wang J; Bloom M; Grompe M; Liu JM
J Cell Physiol; 1999 Apr; 179(1):79-86. PubMed ID: 10082135
[TBL] [Abstract][Full Text] [Related]
4. Fanconi's anemia cell lines show distinct mechanisms of cell death in response to mitomycin C or agonistic anti-Fas antibodies.
Clarke AA; Gibson FM; Scott J; Myatt N; Rutherford TR
Haematologica; 2004 Jan; 89(1):11-20. PubMed ID: 14754601
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic correction of Fanconi anemia in human hematopoietic cells with a recombinant adeno-associated virus vector.
Walsh CE; Nienhuis AW; Samulski RJ; Brown MG; Miller JL; Young NS; Liu JM
J Clin Invest; 1994 Oct; 94(4):1440-8. PubMed ID: 7929819
[TBL] [Abstract][Full Text] [Related]
6. p53-dependent pathway of radio-induced apoptosis is altered in Fanconi anemia.
Rosselli F; Ridet A; Soussi T; Duchaud E; Alapetite C; Moustacchi E
Oncogene; 1995 Jan; 10(1):9-17. PubMed ID: 7824283
[TBL] [Abstract][Full Text] [Related]
7. Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1.
Hussain S; Witt E; Huber PA; Medhurst AL; Ashworth A; Mathew CG
Hum Mol Genet; 2003 Oct; 12(19):2503-10. PubMed ID: 12915460
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of the fanconi anemia group C gene (FAC) protects hematopoietic progenitors from death induced by Fas-mediated apoptosis.
Wang J; Otsuki T; Youssoufian H; Foe JL; Kim S; Devetten M; Yu J; Li Y; Dunn D; Liu JM
Cancer Res; 1998 Aug; 58(16):3538-41. PubMed ID: 9721856
[TBL] [Abstract][Full Text] [Related]
9. Involvement of the Fanconi's anemia protein FAC in a pathway that signals to the cyclin B/cdc2 kinase.
Kruyt FA; Dijkmans LM; Arwert F; Joenje H
Cancer Res; 1997 Jun; 57(11):2244-51. PubMed ID: 9187128
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of TP53 associated genes in Fanconi anemia cells after mitomycin C and hydroxyurea treatment.
Martinez A; Hinz JM; Gómez L; Molina B; Acuña H; Jones IM; Frias S; Coleman MA
Mutat Res; 2008 Oct; 656(1-2):1-7. PubMed ID: 18647660
[TBL] [Abstract][Full Text] [Related]
11. Cellular characterization of cells from the Fanconi anemia complementation group, FA-D1/BRCA2.
Godthelp BC; van Buul PP; Jaspers NG; Elghalbzouri-Maghrani E; van Duijn-Goedhart A; Arwert F; Joenje H; Zdzienicka MZ
Mutat Res; 2006 Oct; 601(1-2):191-201. PubMed ID: 16920162
[TBL] [Abstract][Full Text] [Related]
12. Futile caspase-8 activation during the apoptotic cell death induced by DNA damaging agents in human B-lymphoblasts.
Vit JP; Guillouf C; Rosselli F
Exp Cell Res; 2001 Sep; 269(1):2-12. PubMed ID: 11525634
[TBL] [Abstract][Full Text] [Related]
13. A cross-linker-sensitive myeloid leukemia cell line from a 2-year-old boy with severe Fanconi anemia and biallelic FANCD1/BRCA2 mutations.
Meyer S; Fergusson WD; Oostra AB; Medhurst AL; Waisfisz Q; de Winter JP; Chen F; Carr TF; Clayton-Smith J; Clancy T; Green M; Barber L; Eden OB; Will AM; Joenje H; Taylor GM
Genes Chromosomes Cancer; 2005 Apr; 42(4):404-15. PubMed ID: 15645491
[TBL] [Abstract][Full Text] [Related]
14. 3R coordination by Fanconi anemia proteins.
Macé G; Bogliolo M; Guervilly JH; Dugas du Villard JA; Rosselli F
Biochimie; 2005 Jul; 87(7):647-58. PubMed ID: 15935541
[TBL] [Abstract][Full Text] [Related]
15. Fanconi anemia genes act to suppress a cross-linker-inducible p53-independent apoptosis pathway in lymphoblastoid cell lines.
Kruyt FA; Dijkmans LM; van den Berg TK; Joenje H
Blood; 1996 Feb; 87(3):938-48. PubMed ID: 8562965
[TBL] [Abstract][Full Text] [Related]
16. Aberrant Fanconi anaemia protein profiles in acute myeloid leukaemia cells.
Xie Y; de Winter JP; Waisfisz Q; Nieuwint AW; Scheper RJ; Arwert F; Hoatlin ME; Ossenkoppele GJ; Schuurhuis GJ; Joenje H
Br J Haematol; 2000 Dec; 111(4):1057-64. PubMed ID: 11167740
[TBL] [Abstract][Full Text] [Related]
17. Damage-resistant DNA synthesis in Fanconi anemia cells treated with a DNA cross-linking agent.
Centurion SA; Kuo HR; Lambert WC
Exp Cell Res; 2000 Nov; 260(2):216-21. PubMed ID: 11035916
[TBL] [Abstract][Full Text] [Related]
18. Fanconi anemia C gene product plays a role in the fidelity of blunt DNA end-joining.
Escarceller M; Buchwald M; Singleton BK; Jeggo PA; Jackson SP; Moustacchi E; Papadopoulo D
J Mol Biol; 1998 Jun; 279(2):375-85. PubMed ID: 9642044
[TBL] [Abstract][Full Text] [Related]
19. Fanconi anemia C gene product regulates expression of genes involved in differentiation and inflammation.
Zanier R; Briot D; Dugas du Villard JA; Sarasin A; Rosselli F
Oncogene; 2004 Jun; 23(29):5004-13. PubMed ID: 15077170
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Fanconi Anemia genes in familial breast cancer predisposition.
Seal S; Barfoot R; Jayatilake H; Smith P; Renwick A; Bascombe L; McGuffog L; Evans DG; Eccles D; Easton DF; Stratton MR; Rahman N;
Cancer Res; 2003 Dec; 63(24):8596-9. PubMed ID: 14695169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
